2020 expert consensus statement on neuro-protection after cardiac arrest in China

Dongsheng Fan(King University), Zhi Chen(Tongde Hospital of Zhejiang Province), LI Zhen-zhong(Hebei Medical University), LI Qing-xi(Wuhan Wudong Hospital), Shizheng Wu(Qinghai Provincial Peoples Hospital), Peter S. Pang, Bin Zhao(National University of Singapore), Yuxiang Gu(Fudan University), Xiuchuan Qin(Capital Medical University), Jian Wu, Yongqiu Li(Florida Museum of Natural History), Tao Wang(Peking University), Hongbin Sun(Tsinghua University), Lan Chu(Guiyang Medical University), Liqun Feng(Capital Medical University), Jun Yuan(Jiangyin People's Hospital), Qingbian Ma(Peking University)
Annals of Translational Medicine
January 1, 2021
10.21037/atm-20-7853
Cited by 10

Related Papers

Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
|The Lancet|2022|1k
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
Recognition and Initial Management of Fulminant Myocarditis
|Circulation|2020|593
China stroke surveillance report 2021
|Military Medical Research|2023|554